Article Text

Download PDFPDF
Clinical round-up
  1. Mitesh Desai
  1. Correspondence to Mitesh Desai, Department of HIV/GUM, Lawson Unit, Brighton & Sussex University Hospitals NHS Trust, Eastern Road, Brighton, UK;{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Unselected GUM clinic screening for HCV in MSM is not currently justified

Sexual acquisition of hepatitis C virus (HCV) in men who have sex with men (MSM) is increasingly being reported and associated with unprotected anal sex, fisting and, in particular, known HIV infection. Researchers in London evaluated unselected HCV screening in MSM presenting to the GUM clinic between 1 January and 30 June 2007. Of 3365 MSM attending for sexually transmitted infection (STI) screening, 69% underwent HCV antibody testing. Fifteen patients tested anti-HCV positive (prevalence 0.65%, 95% CI 0.36% to 1.1%). Three of these patients were known to be HIV infected at baseline; the others tested HIV antibody negative at the time of screening. All except three patients had documented HCV risk factors including intravenous drug use and drug insufflation. The prevalence of HCV in HIV-negative MSM or those of unknown HIV status was 0.61% (95% CI 0.31% to 1.1.%)—equivalent to the general UK population. Unselected GUM screening in MSM would cost £84 750/quality-adjusted life year (QALY). Testing only 10% …

View Full Text